Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MorphoSys AG buy knallfrosch44665

Start price
€29.15
28.10.23 / 70%
Target price
-
28.10.24
Performance (%)
130.02%
Price
€67.05
17:35
Summary
This prediction is currently active. The BUY prediction by knallfrosch44665 for MorphoSys AG has seen massive gains of 130.02%. This prediction currently runs until 28.10.24. The prediction end date can be changed by knallfrosch44665 at any time. knallfrosch44665 has 70% into this prediction

MorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.

Performance without dividends (%)
Name 1w 1m
MorphoSys AG 0.829% 0.829%
iShares Core DAX® 4.015% 2.971%
iShares Nasdaq 100 2.755% 0.503%
iShares Nikkei 225® -0.826% -5.057%
iShares S&P 500 2.330% 0.720%

Comments by knallfrosch44665 for this prediction

In the thread Morphosys AG diskutieren

Buy MorphoSys AG

Stopped prediction by knallfrosch44665 for MorphoSys AG

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€81.24
08.03.21
-
08.03.22
-5.02%
22.03.21